Gentle massage technique may boost exercise and life quality in fibromyalgia
NCT ID NCT07641166
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a hands-on technique called manual diaphragmatic release in 60 women with fibromyalgia who are not very active. The goal is to see if it improves exercise capacity, breathing muscle strength, symptoms, and quality of life. Participants will be randomly assigned to receive the massage or a control treatment, and results will be measured after the sessions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Nov 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 55 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Confirmed clinical diagnosis of fibromyalgia fulfilling the American College of Rheumatology diagnostic criteria. * Sedentary or low physical activity status (not participating in structured exercise programs within the past 3 months). Exclusion Criteria: * Severe psychiatric comorbidities (e.g., major depressive disorder with active suicidal ideation) or cognitive impairments. * Presence of comorbid rheumatologic or autoimmune conditions that overlap with muscle/joint symptoms (e.g., severe rheumatoid arthritis, systemic lupus erythematosus). * Primary chronic respiratory/chest diseases (e.g., severe COPD or active asthma). * Cardiovascular disorders or uncontrolled hypertension. * Pregnancy.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Fibromyalgia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can the Body's stress wiring explain why pain spreads and lingers?
- Can qigong loosen the grip of fibromyalgia? trial tests two styles
- Can a light bulb dial down chronic pain?
- Can a Hands-On nerve technique ease Fibromyalgia's grip?
- Why some days hurt more: charting Fibromyalgia's daily swings
- Zapping the vagus nerve: a new hope for fibromyalgia pain?